Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Metastatic Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05430555
What this trial is testing

A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors

Who this might be right for
Advanced Solid Tumors
T-knife GmbH 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05522491
What this trial is testing

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Who this might be right for
Solid Tumor
Hebei Medical University Fourth Hospital 30
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Early research (Phase 1)UnknownNCT00559117
What this trial is testing

A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer

Who this might be right for
Advanced and/or Metastatic Solid Organ Cancer
Vascular Biogenics Ltd. operating as VBL Therapeutics 48
Early research (Phase 1)Not Yet RecruitingNCT05954091
What this trial is testing

OH2 Administered by Intratumoral Injection

Who this might be right for
Solid Tumor
Binhui Biopharmaceutical Co., Ltd. 29
Testing effectiveness (Phase 2)Ended earlyNCT05581719
What this trial is testing

A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Who this might be right for
Solid TumorPeritoneal MetastasesPeritoneal Cancer
Enlivex Therapeutics RDO Ltd. 14
Early research (Phase 1)Study completedNCT01003158
What this trial is testing

Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.

Who this might be right for
NeoplasmsMetastatic CancerBreast Cancer
AstraZeneca 17
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Early research (Phase 1)Study completedNCT03802955
What this trial is testing

Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

Who this might be right for
Solid TumorNon-Hodgkin Lymphoma
Adagene (Suzhou) Limited 62
Not applicableStudy completedNCT02409108
What this trial is testing

Perfusion-Induced Hyperthermia for Metastatic Carcinoma

Who this might be right for
Metastatic Non-Small Cell Lung CarcinomaSolid Tumor, Adult
Jonathan Kiev 4
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Large-scale testing (Phase 3)Study completedNCT01920568
What this trial is testing

Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Fractures, Bone
GlaxoSmithKline 487
Testing effectiveness (Phase 2)UnknownNCT05842785
What this trial is testing

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
Tyligand Bioscience (Shanghai) Limited 162
Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Early research (Phase 1)WithdrawnNCT04797468
What this trial is testing

The CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Henlius Biotech
Early research (Phase 1)Ended earlyNCT01112397
What this trial is testing

Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours

Who this might be right for
Solid Malignancies
AstraZeneca 72
Early research (Phase 1)Study completedNCT05528120
What this trial is testing

Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects

Who this might be right for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Jiangsu vcare pharmaceutical technology co., LTD 16
Testing effectiveness (Phase 2)Study completedNCT06170190
What this trial is testing

A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272590
What this trial is testing

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 290
Next Page